Profil
Peter Friedman worked as a Director-Product Formulation & Master Chemist at Valor Medical, Inc. He completed his undergraduate degree at Tel-Aviv University and his graduate degree at Weizmann Institute of Science.
He also earned a doctorate degree from Weizmann Institute of Science in 1996.
Ehemalige bekannte Positionen von Peter Friedman
| Unternehmen | Position | Ende |
|---|---|---|
Valor Medical, Inc.
 Valor Medical, Inc. Medical SpecialtiesHealth Technology Valor Medical, Inc. develops injectable medical devices. It operates as a medical device company that develops a liquid embolic and malleable polymetric flow diverter technology for the treatment of cerebral aneurysms. The firm provides Neucrylate, a derivative of cyanoacrylate monomer, which changes from liquid to a sponge like material when it comes in contact with blood. Its product serves various neurological applications. The company was founded by Charles W. Kerber in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Peter Friedman
| Tel-Aviv University | Undergraduate Degree |
| Weizmann Institute of Science | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Valor Medical, Inc.
Valor Medical, Inc. Medical SpecialtiesHealth Technology Valor Medical, Inc. develops injectable medical devices. It operates as a medical device company that develops a liquid embolic and malleable polymetric flow diverter technology for the treatment of cerebral aneurysms. The firm provides Neucrylate, a derivative of cyanoacrylate monomer, which changes from liquid to a sponge like material when it comes in contact with blood. Its product serves various neurological applications. The company was founded by Charles W. Kerber in 2007 and is headquartered in San Diego, CA. | Health Technology |
